✦ LIBER ✦

C16 - Racial differences in coronary artery relaxation

✍ Scribed by JL Houghton; VE Smith; WM Breisblatt; NL Henches; DS Strogatz; AA Carr

Book ID: 116155925
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 165 KB
Volume: 8
Category: Article
ISSN: 0895-7061
DOI: 10.1016/0895-7061(95)97788-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Racial differences in outcomes of vetera

Racial differences in outcomes of veterans undergoing coronary artery bypass grafting

✍ C Maynard; J.L Ritchie 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Racial differences in outcomes of vetera

Racial differences in outcomes of veterans undergoing coronary artery bypass grafting

✍ Charles Maynard; James L. Ritchie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Racial differences in long-term survival

Racial differences in long-term survival among patients with coronary artery disease

✍ Kevin L. Thomas; Emily Honeycutt; Linda K. Shaw; Eric D. Peterson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Racial differences in outcome following

Racial differences in outcome following percutaneous coronary intervention

✍ David J. Moliterno 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

Racial differences in the incidence of c

Racial differences in the incidence of coronary sclerosis

✍ Christopher Johnston 📂 Article 📅 1936 🏛 Elsevier Science 🌐 English ⚖ 365 KB

Racial differences in hepatitis C treatm

Racial differences in hepatitis C treatment eligibility

✍ Michael T. Melia; Andrew J. Muir; Jonathan McCone; Mitchell L. Shiffman; John W. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Black Americans are disproportionally infected with hepatitis C virus (HCV) and are less likely than whites to respond to treatment with peginterferon (PEG-IFN) plus ribavirin (RBV). The impact of race on HCV treatment eligibility is unknown. We therefore performed a retrospective analysis of a phas